Literature DB >> 1478848

Interleukin-2 receptor expression on blood monocytes of patients with multiple sclerosis.

M Zaffaroni1, A Ghezzi, L Callea, A Zibetti.   

Abstract

We studied the expression of class II MHC product (HLA DR) and IL-2 receptor on circulating monocytes (M phi) in MS patients, neurological and healthy controls, by double color flow cytometry. In all groups most M phi were DR+ without significant differences. More interesting, low percentages of IL-2+ M phi were detectable in healthy and neurological controls, whilst a few MS patients with active disease showed higher levels. This finding is in agreement with similar studies in other T-cell mediated diseases and with the report of rare IL-2+ macrophages in MS plaques. Although the actual role of IL-2+ M phi in the immune response still needs elucidation, our findings suggest their relevance to the pathological process of demyelinating disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1478848     DOI: 10.1007/bf02334969

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  13 in total

1.  Decreased expression of HLA-DR antigens on monocytes in patients with multiple sclerosis.

Authors:  C N Baxevanis; G J Reclos; P Arsenis; E Anastasopoulos; A Katsiyiannis; P Lymberi; N Matikas; M Papamichail
Journal:  J Neuroimmunol       Date:  1989-05       Impact factor: 3.478

2.  Monocytes constitute the only peripheral blood cell population showing an increased burst activity in multiple sclerosis patients.

Authors:  K P Hammann; H C Hopf
Journal:  Int Arch Allergy Appl Immunol       Date:  1986

3.  Ecto-5'nucleotidase activity in B and T lymphocytes and monocytes of patients with multiple sclerosis.

Authors:  M A Armstrong; M Haire
Journal:  Ann Neurol       Date:  1986-01       Impact factor: 10.422

4.  Activated (IL-2R+) intraglomerular mononuclear cells in crescentic glomerulonephritis.

Authors:  H L Li; W W Hancock; J P Dowling; R C Atkins
Journal:  Kidney Int       Date:  1991-04       Impact factor: 10.612

5.  Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis. Immunohistologic evidence that inflammatory macrophages express IL-2 receptors.

Authors:  W W Hancock; L Kobzik; A J Colby; C J O'Hara; A G Cooper; J J Godleski
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

Review 6.  Current concepts: immunology. Monocytes and macrophages.

Authors:  R B Johnston
Journal:  N Engl J Med       Date:  1988-03-24       Impact factor: 91.245

7.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

Review 8.  Interleukin 2 receptors.

Authors:  M Allouche; Y Sahraoui; Y Augery-Bourget; M Perrakis; C Jasmin; V Georgoulias
Journal:  Leuk Res       Date:  1990       Impact factor: 3.156

9.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

10.  The interleukin 2 receptor. Functional consequences of its bimolecular structure.

Authors:  H M Wang; K A Smith
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  1 in total

1.  Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1).

Authors:  R Balabanov; D Lisak; T Beaumont; R P Lisak; P Dore-Duffy
Journal:  Clin Diagn Lab Immunol       Date:  2001-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.